Intralipid Infusion to Fetal Sheep ( <scp> <i>Ovis aries</i> </scp> ) Promotes Differentiation and Lipid Accumulation of Adipose Tissues

Intralipid is a lipid emulsion used for preterm infants, but its biological effects on adipose development remain poorly examined. We investigated the effects of intravenous Intralipid on the adipose tissue development of midgestation fetal sheep. Intralipid20 infusion was started in fetuses at 88-90 days of gestation (dG) following clinical infant dosing guidance (0.5-1 g/kg/d estimated body weight, increasing daily by 0.5-1 g/kg/d to a maximum of 3 g/kg/d). Intralipid increased perirenal fat weight, adipocyte size, and lipid accumulation. Expression of key adipogenic genes was upregulated, including Pparg (Peroxisome Proliferator-Activated Receptor Gamma), Fasn (Fatty Acid Synthase), Fabp4 (Adipocyte Fatty Acid Binding Protein 4), Acca (Acetyl-CoA Carboxylase α), and Cebpa (CCAAT/Enhancer-Binding Protein Alpha), while downregulating Pdgfra (Platelet-Derived Growth Factor Receptor Alpha), Cidea (Cell death-inducing DNA fragmentation factor α-like effector A), Ppargc1a (Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-Alpha), and Ucp1 (Uncoupling Protein 1). Similar changes were confirmed in omental fat. Intralipid elicited mild inflammation in both perirenal and omental fat by increasing the expression of Tnfa (Tumor Necrosis Factor-Alpha), with upregulation of Tlr4 (Toll-Like Receptor-4), and Tlr2 (Toll-Like Receptor-2) specifically in perirenal fat. Notably, this inflammatory response occurred without elevation of Il-6 (Interleukin-6) expression or NF-κB activation. Moreover, Intralipid treatment suppressed the expression of fibrosis-related genes, including Lh2b (lysyl oxidase-like 2b) and P4ha (prolyl 4-hydroxylase). These findings suggest that Intralipid administration at a developmental stage prior to normal term enhances ovine adipogenic differentiation and lipid accumulation which might be protective to premature infants, but it might slightly induce inflammation in the adipose tissues.

Authors

Institutions

Publication Details

Journal
The FASEB Journal
Published
2025-10-29
DOI
https://doi.org/10.1096/fj.202502000r
Primary Topic
Birth, Development, and Health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intralipid Infusion to Fetal Sheep ( Ovis aries ) Promotes Differentiation and Lipid Accumulation of Adipose Tissues

Sonnet S. Jonker, Samantha Louey, ‬Min Du, Sarah Alaniz et al.
The FASEB Journal
Birth, Development, and Health
article

Intralipid Infusion to Fetal Sheep ( Ovis aries ) Promotes Differentiation and Lipid Accumulation of Adipose Tissues

Sonnet S. Jonker, Samantha Louey, ‬Min Du, Sarah Alaniz, Jeanene M. de Avila, Xinrui Li
article en

Abstract

Intralipid is a lipid emulsion used for preterm infants, but its biological effects on adipose development remain poorly examined. We investigated the effects of intravenous Intralipid on the adipose tissue development of midgestation fetal sheep. Intralipid20 infusion was started in fetuses at 88-90 days of gestation (dG) following clinical infant dosing guidance (0.5-1 g/kg/d estimated body weight, increasing daily by 0.5-1 g/kg/d to a maximum of 3 g/kg/d). Intralipid increased perirenal fat weight, adipocyte size, and lipid accumulation. Expression of key adipogenic genes was upregulated, including Pparg (Peroxisome Proliferator-Activated Receptor Gamma), Fasn (Fatty Acid Synthase), Fabp4 (Adipocyte Fatty Acid Binding Protein 4), Acca (Acetyl-CoA Carboxylase α), and Cebpa (CCAAT/Enhancer-Binding Protein Alpha), while downregulating Pdgfra (Platelet-Derived Growth Factor Receptor Alpha), Cidea (Cell death-inducing DNA fragmentation factor α-like effector A), Ppargc1a (Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-Alpha), and Ucp1 (Uncoupling Protein 1). Similar changes were confirmed in omental fat. Intralipid elicited mild inflammation in both perirenal and omental fat by increasing the expression of Tnfa (Tumor Necrosis Factor-Alpha), with upregulation of Tlr4 (Toll-Like Receptor-4), and Tlr2 (Toll-Like Receptor-2) specifically in perirenal fat. Notably, this inflammatory response occurred without elevation of Il-6 (Interleukin-6) expression or NF-κB activation. Moreover, Intralipid treatment suppressed the expression of fibrosis-related genes, including Lh2b (lysyl oxidase-like 2b) and P4ha (prolyl 4-hydroxylase). These findings suggest that Intralipid administration at a developmental stage prior to normal term enhances ovine adipogenic differentiation and lipid accumulation which might be protective to premature infants, but it might slightly induce inflammation in the adipose tissues.

The FASEB JournalVol. 39(21)
Oregon Health & Science University (US), Washington State University (US)
National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Child Health and Human Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Openalex Percentile: Top 56%
Birth, Development, and Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.